FDA approves Medtronic's Bluetooth-controlled insulin pump for children  ages 2 and up | FierceBiotech

When it comes to diabetes, frequent sugar tests and insulin administration throughout the day are not easy processes for an adult, let alone a child.

With this in mind, a device named Medtronic's MiniMed 770G has recently been created, which has been approved by the FDA (Food and Drug Administration) as the first of its kind to be used in children ages 2 to 6 with type 1 diabetes and can also be used by people outside that age range.

Thus the MiniMed 770G is presented as the successor to the MiniMed 760G (this being the first automated insulin system endorsed by the FDA in 2016) with significant improvements and Bluetooth connection.

FDA Approves First Implantable CGM for Diabetics | Everyday Health

For approval, the MiniMed 770G was tested for a period of 3 months in 46 children with type 1 diabetes who used the device both inside and outside their homes, successfully demonstrating the usability of the device by the child population located in this age range.

With MiniMed 770G it is possible to measure the glucose levels present in the child every 5 minutes thanks to the sensor of the device connected to his body. It also has a pump and an infusion patch attached to the pump, along with a catheter that allows insulin to be administered.

In the end, the MiniMed 770G works by adjusting or retaining insulin automatically as part of the process of regulating sugar in the patient, and this can be done without the intervention of the caregiver, although the caregiver must administer insulin manually after meals. It should be noted that children under 2 years old will not be eligible to use the MiniMed.

Post a Comment